A Retrospective study comparing the efficacy and safety of Brincidofovir and Cidofovir in controlling HCT-related adenoviremia in Pediatric patients

Trial Profile

A Retrospective study comparing the efficacy and safety of Brincidofovir and Cidofovir in controlling HCT-related adenoviremia in Pediatric patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Feb 2017

At a glance

  • Drugs Brincidofovir (Primary) ; Cidofovir
  • Indications Adenovirus infections
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 08 Feb 2017 New trial record
    • 02 Feb 2017 Results published in the Blood
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top